doi: 10.2337/dc10-1393
Kalinderi K, Papaliagkas V, Fidani L
The problem is that semaglutide and tirzepatide often produce much faster weight loss than this, particularly in the first few months
If you havent had lab work done in the last year, labs will be ordered for your care team to gain insights into your unique metabolism so that you can work together to shape a personalized care plan
Key safety signals observed in the Phase 2 trial included gastrointestinal adverse effects (nausea, vomiting, diarrhoea, and constipation), increases in resting heart rate, and gallbladder-related events consistent with the broader class of incretin-based therapies
Surgical intervention linked to increased lifespan and reduced complications Image content: This image is available to view online